Remicade (infliximab) Drug Market Report

China Remicade (infliximab) Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 20, 2022
  • PAGES：206
  • REPORT CODE：GMM1039193
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Remicade (infliximab) Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Remicade (infliximab) Drug market. Detailed analysis of key players, along with key growth strategies adopted by Remicade (infliximab) Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Epirus Biopharmaceuticals

    • Celltrion Healthcare

    • Samsung Bioepsis

    • Janssen

    • Hospira

    By Type:

    • Brands Drugs

    • Generic Drugs

    By End-User:

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    • Generic Drugs

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Remicade (infliximab) Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Remicade (infliximab) Drug Market Size and Growth Rate of Brands Drugs from 2016 to 2027

    • 1.3.2 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.4.2 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.4.3 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.4.4 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.4.5 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.4.6 China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Remicade (infliximab) Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Remicade (infliximab) Drug by Major Types

    • 3.4.1 Market Size and Growth Rate of Brands Drugs

    • 3.4.2 Market Size and Growth Rate of Generic Drugs

    4 Segmentation of Remicade (infliximab) Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Remicade (infliximab) Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Remicade (infliximab) Drug in Generic Drugs

    • 4.4.2 Market Size and Growth Rate of Remicade (infliximab) Drug in Generic Drugs

    • 4.4.3 Market Size and Growth Rate of Remicade (infliximab) Drug in Generic Drugs

    • 4.4.4 Market Size and Growth Rate of Remicade (infliximab) Drug in Generic Drugs

    • 4.4.5 Market Size and Growth Rate of Remicade (infliximab) Drug in Generic Drugs

    • 4.4.6 Market Size and Growth Rate of Remicade (infliximab) Drug in Generic Drugs

    5 Market Analysis by Regions

    • 5.1 China Remicade (infliximab) Drug Production Analysis by Regions

    • 5.2 China Remicade (infliximab) Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Remicade (infliximab) Drug Landscape Analysis

    • 6.1 North China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 6.2 North China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    7 Central China Remicade (infliximab) Drug Landscape Analysis

    • 7.1 Central China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 7.2 Central China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    8 South China Remicade (infliximab) Drug Landscape Analysis

    • 8.1 South China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 8.2 South China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    9 East China Remicade (infliximab) Drug Landscape Analysis

    • 9.1 East China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 9.2 East China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    10 Northeast China Remicade (infliximab) Drug Landscape Analysis

    • 10.1 Northeast China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 10.2 Northeast China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    11 Southwest China Remicade (infliximab) Drug Landscape Analysis

    • 11.1 Southwest China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 11.2 Southwest China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    12 Northwest China Remicade (infliximab) Drug Landscape Analysis

    • 12.1 Northwest China Remicade (infliximab) Drug Landscape Analysis by Major Types

    • 12.2 Northwest China Remicade (infliximab) Drug Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Epirus Biopharmaceuticals

      • 13.1.1 Epirus Biopharmaceuticals Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Celltrion Healthcare

      • 13.2.1 Celltrion Healthcare Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Samsung Bioepsis

      • 13.3.1 Samsung Bioepsis Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Janssen

      • 13.4.1 Janssen Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Hospira

      • 13.5.1 Hospira Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Brands Drugs from 2016 to 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure China Remicade (infliximab) Drug Market Size and Growth Rate of Generic Drugs from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Remicade (infliximab) Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Remicade (infliximab) Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Remicade (infliximab) Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Remicade (infliximab) Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Remicade (infliximab) Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Brands Drugs

    • Figure Market Size and Growth Rate of Generic Drugs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Remicade (infliximab) Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Remicade (infliximab) Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Generic Drugs

    • Figure Market Size and Growth Rate of Generic Drugs

    • Figure Market Size and Growth Rate of Generic Drugs

    • Figure Market Size and Growth Rate of Generic Drugs

    • Figure Market Size and Growth Rate of Generic Drugs

    • Figure Market Size and Growth Rate of Generic Drugs

    • Table China Remicade (infliximab) Drug Production by Regions

    • Table China Remicade (infliximab) Drug Production Share by Regions

    • Figure China Remicade (infliximab) Drug Production Share by Regions in 2016

    • Figure China Remicade (infliximab) Drug Production Share by Regions in 2021

    • Figure China Remicade (infliximab) Drug Production Share by Regions in 2027

    • Table China Remicade (infliximab) Drug Consumption by Regions

    • Table China Remicade (infliximab) Drug Consumption Share by Regions

    • Figure China Remicade (infliximab) Drug Consumption Share by Regions in 2016

    • Figure China Remicade (infliximab) Drug Consumption Share by Regions in 2021

    • Figure China Remicade (infliximab) Drug Consumption Share by Regions in 2027

    • Table North China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table North China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure North China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure North China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure North China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table North China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table North China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure North China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure North China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure North China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table Central China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table Central China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure Central China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure Central China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure Central China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table Central China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table Central China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure Central China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure Central China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table South China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table South China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure South China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure South China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure South China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table South China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table South China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure South China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure South China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table East China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table East China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure East China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure East China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure East China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table East China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table East China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure East China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure East China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure East China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table Northeast China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table Northeast China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure Northeast China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure Northeast China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table Northeast China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure Northeast China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure Northeast China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table Southwest China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table Southwest China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure Southwest China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure Southwest China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table Southwest China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table Southwest China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure Southwest China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure Southwest China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table Northwest China Remicade (infliximab) Drug Consumption by Types from 2016 to 2027

    • Table Northwest China Remicade (infliximab) Drug Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Remicade (infliximab) Drug Consumption Share by Types in 2016

    • Figure Northwest China Remicade (infliximab) Drug Consumption Share by Types in 2021

    • Figure Northwest China Remicade (infliximab) Drug Consumption Share by Types in 2027

    • Table Northwest China Remicade (infliximab) Drug Consumption by End-Users from 2016 to 2027

    • Table Northwest China Remicade (infliximab) Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Remicade (infliximab) Drug Consumption Share by End-Users in 2016

    • Figure Northwest China Remicade (infliximab) Drug Consumption Share by End-Users in 2021

    • Figure Northwest China Remicade (infliximab) Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Epirus Biopharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Epirus Biopharmaceuticals

    • Figure Sales and Growth Rate Analysis of Epirus Biopharmaceuticals

    • Figure Revenue and Market Share Analysis of Epirus Biopharmaceuticals

    • Table Product and Service Introduction of Epirus Biopharmaceuticals

    • Table Company Profile and Development Status of Celltrion Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion Healthcare

    • Figure Sales and Growth Rate Analysis of Celltrion Healthcare

    • Figure Revenue and Market Share Analysis of Celltrion Healthcare

    • Table Product and Service Introduction of Celltrion Healthcare

    • Table Company Profile and Development Status of Samsung Bioepsis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepsis

    • Figure Sales and Growth Rate Analysis of Samsung Bioepsis

    • Figure Revenue and Market Share Analysis of Samsung Bioepsis

    • Table Product and Service Introduction of Samsung Bioepsis

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US